HUTCHMED (HCM) News Today → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free HCM Stock Alerts $16.80 -0.05 (-0.30%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDo Its Financials Have Any Role To Play In Driving HUTCHMED (China) Limited's (LON:HCM) Stock Up Recently?finance.yahoo.com - March 28 at 7:10 AMHUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLCglobenewswire.com - March 27 at 8:00 PMHUTCHMED (NASDAQ:HCM) Rating Increased to Buy at StockNews.comamericanbankingnews.com - March 27 at 2:08 AMHUTCHMED (NASDAQ:HCM) Sees Unusually-High Trading Volumemarketbeat.com - March 25 at 1:34 PMHUTCHMED (NASDAQ:HCM) Shares Down 5% americanbankingnews.com - March 24 at 3:08 AMHUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in Chinaglobenewswire.com - March 21 at 8:00 PMHUTCHMED (NASDAQ:HCM) Shares Gap Down to $17.34marketbeat.com - March 21 at 3:51 PMHutchmed Is Turning Profitableseekingalpha.com - March 20 at 8:55 AMHUTCHMED (NASDAQ:HCM) Downgraded by StockNews.comamericanbankingnews.com - March 19 at 2:28 AMHUTCHMED (NASDAQ:HCM) Stock Price Up 5.5%marketbeat.com - March 15 at 12:37 PMAffimed N.V., Hutchmed, Annexon among healthcare moversmsn.com - March 14 at 10:33 AMHUTCHMED (NASDAQ:HCM) Raised to Buy at StockNews.commarketbeat.com - March 11 at 11:15 PMHUTCHMED (China) Limited (NASDAQ:HCM) Stake Cut by Schroder Investment Management Groupmarketbeat.com - March 7 at 8:59 AMHUTCHMED (NASDAQ:HCM) Shares Gap Down to $15.12marketbeat.com - March 5 at 1:23 PMHUTCHMED (China) Limited (HCM) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 1 at 12:16 PMHUTCHMED (China) Full Year 2023 Earnings: EPS: US$0.12 (vs US$0.43 loss in FY 2022)finance.yahoo.com - March 1 at 2:14 AMHUTCHMED Reports 2023 Full Year Results and Provides Business Updatesglobenewswire.com - February 28 at 6:30 AMHUTCHMED (HCM) to Release Quarterly Earnings on Wednesdaymarketbeat.com - February 27 at 2:26 AMAcadian Asset Management LLC Makes New Investment in HUTCHMED (China) Limited (NASDAQ:HCM)marketbeat.com - February 25 at 6:23 AMHCM Mar 2024 17.500 callfinance.yahoo.com - February 17 at 10:11 AMHUTCHMED (NASDAQ:HCM) Shares Gap Down to $14.01marketbeat.com - February 14 at 12:01 PMHUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Sessionfinance.yahoo.com - February 6 at 9:18 PMHUTCHMED (NASDAQ:HCM) Shares Gap Up to $12.08marketbeat.com - February 6 at 11:39 AMHUTCHMED (China) Limited: HUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic Partnershipfinanznachrichten.de - February 2 at 9:46 AMInmagene Exercises Option to Obtain Exclusive Worldwide License for IMG-007 and IMG-004 from HUTCHMEDfinance.yahoo.com - February 2 at 9:46 AMHUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancerfinance.yahoo.com - January 30 at 12:47 AMHUTCHMED (NASDAQ:HCM) Sees Strong Trading Volumemarketbeat.com - January 29 at 1:35 PMHUTCHMED (China) Limited (NASDAQ:HCM) Sees Large Decrease in Short Interestmarketbeat.com - January 17 at 12:44 AMChinese regulators accept HUTCHMED application for solveplenibmsn.com - January 11 at 1:15 PMHUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Statusfinance.yahoo.com - January 10 at 8:03 PMHUTCHMED (China) Limited (NASDAQ:HCM) Short Interest Updatemarketbeat.com - January 3 at 9:19 PMHUTCHMED (China) Limited (0013.HK)ca.finance.yahoo.com - December 24 at 1:30 PMHUTCHMED (China) Limited Forecasted to Earn FY2023 Earnings of $0.23 Per Share (NASDAQ:HCM)marketbeat.com - December 21 at 7:46 AMHUTCHMED (NASDAQ:HCM) Stock Rating Reaffirmed by Cantor Fitzgeraldmarketbeat.com - December 21 at 7:36 AMHUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Termsfinance.yahoo.com - December 13 at 3:26 AMHUTCHMED Announces that it has Completed Enrollment of a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in Chinafinance.yahoo.com - December 12 at 9:56 PMUniSuper Management Pty Ltd Invests $6.84 Million in HUTCHMED (China) Limited (NASDAQ:HCM)marketbeat.com - December 8 at 7:41 AMHUTCHMED (China) Limited: HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congressesfinanznachrichten.de - December 1 at 10:12 PMHUTCHMED Deserves An Upgrade After U.S. FDA Approval Of Cancer Drugseekingalpha.com - December 1 at 12:11 PMGoldman Sachs Maintains Neutral Rating for HUTCHMED (China): Here's What You Need To Knowmarkets.businessinsider.com - November 10 at 12:51 PMHUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancerfinance.yahoo.com - November 8 at 10:45 PMHutchmed: Progressing, But We Would Like More Clarity On Profit Marginsseekingalpha.com - October 19 at 6:23 PMWall Street Analysts See a 107.24% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?finance.yahoo.com - October 3 at 1:24 PMHUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancerfinance.yahoo.com - September 12 at 5:26 AMVanguard Personalized Indexing Management LLC Invests $131,000 in HUTCHMED (China) Limited (NASDAQ:HCM)marketbeat.com - September 4 at 5:04 AMBarclays PLC Purchases 35,883 Shares of HUTCHMED (China) Limited (NASDAQ:HCM)marketbeat.com - August 27 at 4:03 AMHutchmed's Candidate Achieves Main Goal In China's Rare Blood Disorder Studymsn.com - August 21 at 5:41 PMHUTCHMED : Sovleplenib Phase III ESLIM-01 Study Meets Main Goal In Primary Immune Thrombocytopeniamarkets.businessinsider.com - August 20 at 10:24 PMHUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary Immune Thrombocytopenia in Chinafinance.yahoo.com - August 20 at 10:24 PMHCM - HUTCHMED (China) Limitedca.finance.yahoo.com - August 13 at 11:19 AM Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Major Elon Musk Crypto Leak Revealed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. HCM Media Mentions By Week HCM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.860.60▲Average Medical News Sentiment HCM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼81▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ACAD News INDV News ARVN News CRNX News MOR News IDYA News SMMT News MLTX News MRUS News EVO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubThe 3rd Revolution in WarfareWeiss RatingsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.